Skip to main content
Year archive

RECCE PHARMACEUTICALS LTD — 2021 filings

All 62 regulatory filings released by RECCE PHARMACEUTICALS LTD (RCE) in 2021, sourced directly from the official regulator.

62 Filings
2021 Period
2021 filings (62)
Filing Released Lang
Patients to be Dosed in Ph 1 IV Clinical Trial of R327 2 pages 254.4KB
Regulatory Filings
2021-12-14 English
Update on Phase I/II Clinical Trial for Burn Wound Infection 3 pages 281.9KB
Regulatory Filings
2021-12-06 English
AGM Presentation 11 pages 2.2MB
Regulatory Filings
2021-11-21 English
Results of Meeting 2 pages 185.1KB
Regulatory Filings
2021-11-21 English
Opening R&D Address at World AMR Congress 32 pages 7.1MB
Regulatory Filings
2021-11-07 English
Appendix 4C and Activity Report 9 pages 424.7KB
Regulatory Filings
2021-10-28 English
Ethics Approval to Start Phase 1 Intravenous Clinical Trial 3 pages 256.6KB
Regulatory Filings
2021-10-24 English
Notice of General Meeting/Proxy Form 23 pages 873.6KB
Regulatory Filings
2021-10-21 English
Letter to Shareholders - Annual General Meeting 2 pages 234.8KB
Regulatory Filings
2021-10-21 English
Suspension from Official Quotation 2 pages 248.0KB
Regulatory Filings
2021-10-11 English
Court Orders Granted 4 pages 416.8KB
Regulatory Filings
2021-10-11 English
Reinstatement to Official Quotation 1 page 89.1KB
Regulatory Filings
2021-10-11 English
Pause in Trading 1 page 111.8KB
Regulatory Filings
2021-10-07 English
Trading halt 2 pages 715.9KB
Regulatory Filings
2021-10-07 English
Court application and delayed cleansing notice 2 pages 247.4KB
Regulatory Filings
2021-10-07 English
Application for quotation of securities - RCE 6 pages 27.7KB
Regulatory Filings
2021-10-07 English
R327 Phase I Clinical Trial Registered on ANZCTR 2 pages 297.5KB
Regulatory Filings
2021-09-29 English
Appendix 4E 2 pages 271.7KB
Regulatory Filings
2021-08-30 English
Annual Report to shareholders 76 pages 5.9MB
Regulatory Filings
2021-08-30 English
Appendix 4G 12 pages 277.5KB
Regulatory Filings
2021-08-30 English
Change in substantial holding 3 pages 224.5KB
Regulatory Filings
2021-08-15 English
Recce Receives Further Innovation Connections Grant 2 pages 231.0KB
Regulatory Filings
2021-08-10 English
Appendix 4C and Activity Report 10 pages 446.5KB
Regulatory Filings
2021-07-29 English
Corporate Presentation 26 pages 4.9MB
Regulatory Filings
2021-07-26 English
Anti-Viral Patent Granted in USA for RECCE Anti-Infectives 2 pages 278.1KB
Regulatory Filings
2021-07-21 English
Anti-Viral Patent Granted in China 2 pages 278.1KB
Regulatory Filings
2021-07-19 English
Outstanding Efficacy Against Flesh-Eating Bacteria 3 pages 435.5KB
Regulatory Filings
2021-07-18 English
Multiple Patients Dosed in Topical Phase I/II Clinical Trial 3 pages 306.6KB
Regulatory Filings
2021-07-11 English
Bonus Canadian R&D Rebate Received 2 pages 276.4KB
Regulatory Filings
2021-07-04 English
Change of Director's Interest Notices - J Graham & M Dilizia 6 pages 448.6KB
Regulatory Filings
2021-06-21 English
Recce Pharmaceuticals to Present at World Microbe Forum 2 pages 317.6KB
Regulatory Filings
2021-06-17 English
Recce to Present at MST Access Investor Conference 30 pages 5.1MB
Regulatory Filings
2021-06-16 English
Recce Clinical Pipeline Update 3 pages 303.0KB
Regulatory Filings
2021-06-06 English
Corporate Presentation - EU Non-Deal Roadshow 36 pages 4.0MB
Regulatory Filings
2021-06-06 English
R327 Demonstrates World First Multiple Mechanisms of Action 8 pages 1.3MB
Regulatory Filings
2021-05-26 English
R327 to Stage 2 of SARS-CoV-2 Antiviral Screening at CSIRO 3 pages 339.3KB
Regulatory Filings
2021-05-18 English
Positive Data on RECCE 327 Against All Six ESKAPE Pathogens 5 pages 906.4KB
Regulatory Filings
2021-05-03 English
Appendix 4C and Activity Report 9 pages 469.1KB
Regulatory Filings
2021-04-26 English
RECCE 327 Registered for Topical Burns Study in Humans 2 pages 306.0KB
Regulatory Filings
2021-04-14 English
Positive Sinusitis Patient Update - Special Access Scheme 4 pages 309.4KB
Regulatory Filings
2021-04-06 English
Positive Sinusitis Data Against Infection 5 pages 637.7KB
Regulatory Filings
2021-03-31 English
Anti-Viral Patent Granted in EU for RECCE Anti-Infectives 2 pages 194.0KB
Regulatory Filings
2021-03-29 English
Pew Charitable Trusts adds R327 to Antibiotic Treatment List 3 pages 358.4KB
Regulatory Filings
2021-03-14 English
Recce Presenting at H.C. Wainwright Life Sciences Conference 33 pages 3.6MB
Regulatory Filings
2021-03-09 English
Recce Pharmaceuticals Dual Lists on Frankfurt Stock Exchange 2 pages 340.0KB
Regulatory Filings
2021-03-07 English
Appendix 4D and Half Yearly Report 26 pages 461.7KB
Regulatory Filings
2021-02-24 English
Appendix 2A 15 pages 277.0KB
Regulatory Filings
2021-02-24 English
Cleansing Statement 1 page 243.5KB
Regulatory Filings
2021-02-24 English
Change of Director's Interest Notice 3 pages 219.6KB
Regulatory Filings
2021-02-24 English
Change of Director's Interest Notice 2 pages 185.1KB
Regulatory Filings
2021-02-24 English
Change of Director's Interest Notice 2 pages 185.4KB
Regulatory Filings
2021-02-24 English
Change of Director's Interest Notice 2 pages 217.4KB
Regulatory Filings
2021-02-24 English
Change of Director's Interest Notice 2 pages 219.3KB
Regulatory Filings
2021-02-24 English
Recce Applies for Dual Listing on Frankfurt Stock Exchange 2 pages 335.6KB
Regulatory Filings
2021-02-23 English
Appendix 3G 12 pages 278.6KB
Regulatory Filings
2021-02-21 English
Fiona Stanley Hospital Phase I/II Clinical Trial Agreement 3 pages 426.4KB
Regulatory Filings
2021-02-15 English
Further Encouraging COVID Results at Doherty 3 pages 410.4KB
Regulatory Filings
2021-02-11 English
R&D Incentive Rebate Received 2 pages 335.8KB
Regulatory Filings
2021-02-02 English
Appendix 4C and Activity Report 8 pages 547.5KB
Regulatory Filings
2021-01-27 English
Appendix 2A 15 pages 203.9KB
Regulatory Filings
2021-01-18 English
Cleansing Statement 1 page 267.3KB
Regulatory Filings
2021-01-18 English
Corporate Presentation 29 pages 4.8MB
Regulatory Filings
2021-01-07 English